Azafaros

Study to Understand Fatal Genetic Diseases in Children Becomes First to Incorporate a Digital Participant Education Programme

June 9, 2022 - A pioneering clinical trial was launched last week to help researchers understand how two rare and fatal genetic diseases develop in children and provide insight into treatment for them in the future. The study, run by Azafaros, will follow patients in the UK, US, France, Italy, Germany and Brazil for four...
Azafaros B.V., Gooimeer 2-35, 1411 DC Naarden, The Netherlands